This act will allow individuals and families better access to clinical trials without the income-related barriers.
Today, 30 million people and their families have added hope that their tremendous unmet medical needs are one step closer to being addressed. Studying one rare disease can often lead to understanding of other rare diseases, as well as understanding of more common diseases. - Peter Saltonstall, President and CEO, National Organization of Rare Disorders (NORD)
To learn more about the Ensuring Access to Clinical Trials Act
(S. 139), visit the link below and stay tuned to future calls for action. Together we can!
|